Eritema fijo medicamentoso no pigmentado

Anales Espanoles de Pediatria

Volumn 45, Issue 6, 1996, Pages 642-644

  Garcia Puga J M ^a,c   Thomas Carazo, E ^a   Morata Cespedes M C ^a   Caballero Garcia S ^a   Recalde Manrique, J M ^b  

^a Ctro de Salud Salvador C   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMBROXOL;

ARTICLE; CASE REPORT; ERYTHEMA; HUMAN; MALE; RASH; SCHOOL CHILD; SKIN PIGMENTATION;

AMBROXOL; CHILD; DRUG ERUPTIONS; ERYTHEMA; HUMANS; MALE;

EID: 0030500411     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sehgal VN, Gangwani OP. Fixed drug eruptions. Current concepts. Int J Dermatol 1987;26:67-74.
2. Pelta Fernández R, Vivas Rojo E. Toxicodermias: Manifestaciones clínicas y medicamentos implicados en reacciones adversas medicamentosas. En: Reacciones adversas medicamentosas. Madrid: Díaz de Santos, 1992;259-271.
3. Añibarro Bausela B, Berto Salort JM, García Ara MC, Díaz Pena JM, Ojeda Casas JA. Reacciones alérgicas a medicamentos en niños. An Esp Pediatr 1992;36:447-450.
4. Bharija SC, Singh M, Belhaj MS. Fixed drug eruption in an 8-month-old infant. Dermatologica 1988;176:108.
5. Zanolli MD, McAlvany J, Krowchuk DP. Eritema fijo medicamentoso inducido por fenolftaleína: Complicatión cutánea del empleo de laxantes en un niño. Pediatrics (ed esp) 1993;35:343-345.
6. De Groot AC, Nater JP. Dermatological drugs, topical agents and cosmetic en: Dukes MNG, Beeley (eds). Side Effects of Drugs Annual, 14. Amsterdam: Elsevier 1990;124-134.
7. Mancuso G, Berdondini RM. Contact allergy to ambroxol. Contact Derm 1989;20:154.
8. Oliveri D y cols. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multiceter study versus placebo. Respiration 1991;58:117-121. (En: Bromhexine. Drug evaluation monographs. Gelman CR, Rumack BH, eds. Drugdex Information System. Micromedex , Inc. Denver, Colorado; edition expirex 31-3-95).
9. Anderson JAA, Adkinson NF. Allergin reactions to drugs and biological agents. JAMA 1987;258:2891-2899.
10. Korkj W, Soltani K. Fixed drug eruption. A brief review. Arch Dermatol 1984;120:520-524.
11. Stephen JR, Benson PM. Non-pigmenting fixed drug eruption. J Am Acad Dermatol 1994;31:292-292.
12. Benson PM, Giblin WJ, Douglas DM. Transient, non-pigmeting fixed drug eruption caused by radiopaque contrast media. J Am Acad Dermatol 1990;23:379-381.
13. Desmeules H. Non-pigmenting fixed drug eruption after enesthesia. Anesth Analg 1990;70:26-217.
14. Bharija SC, Belhaj MS. Fixed drug eruption on three independent sites induced by thre chemically unrelated drugs Dermatologica 1990;181:237.
15. Kanwat AJ y cols. Fixed drug eruption due to tinidazole with cross. Reactivity with tinidazole. Dermatologica 1990;180:276.
16. Shiohara T, Nickloff BJ, Sagawa Y, Gomi T, Nagashima M. Fixed drug eruption. Arch Dermatol 1989;125:1371-1376.
17. Hindsen M y cols. Fixed drug eruption: An immunohistochemical investigation of the acute and healing phase. Br T Dermatol 1987;116:351-360.
18. Pellicano R, Ciavarella G, Lomuto M, Di Giorgio G. Genetic Susceptibility to fixed drug eruption: Evidence for a link with HLA-B22. J Am Acad Dermatol 1994;30:52-54.
19. Stubb S. Blood Leukocytes, with special reference to basophils and esonophils, during provocation tests in fixed eruption and drug exantema. Acta Dermatol Venereal 1976;56:1-47.
20. Kanwar AJ, Bharija SC, Singh M, Belhaj MS. Ninenty-eight fixed drug eruption with provocation test. Dermatologica 1988;177:274-279.
21. Lee AY, Lee YS. Provocation test in a chlormenazonone-induced fixed drug. DICP 1991;25:604-605.